PHARMAIDS PHARMACEUTICALS LTD. Share Price

₹ 28.14

+₹0.42 (1.52%)
1D
Last updated 02 Nov, 2026, 15:57 IST
BSE: 524572
|
Pharmaceuticals

PHARMAIDS PHARMACEUTICALS LTD. Share Price Today

As of 2 Nov 2026, PHARMAIDS PHARMACEUTICALS LTD. share price is ₹28.14. The stock opened at ₹27.80, compared to its previous close of ₹27.72. During today's trading session, PHARMAIDS PHARMACEUTICALS LTD. share price moved in the range of ₹27.80 to ₹29.00, with an average price of ₹28.40 for the day. Looking at its last 52-week, the stock has touched a low of ₹25.60 and a high of ₹53.90.

Share price over the last 1 day fell from 28.80 to 28.14, ranging between 27.80 and 29.00.
₹27.80
1.52% up today
₹29.00
1D LOW
1D HIGH

PHARMAIDS PHARMACEUTICALS LTD. Stock Insights

Latest Earning
Op Profit TrendUp by 265.07% QoQ
Latest Earning
Net Profit TrendUp by 273.15% QoQ
Latest Earning
Revenue TrendUp by 44.09% YoY
Stock Performance
UnderperformingUnderperforming Nifty by 33.84 % in last 1 yr
PHARMAIDS PHARMACEUTICALS LTD. stock performance
Open₹27.80
High₹29.00
Low₹27.80
Prev. close₹27.72
PHARMAIDS PHARMACEUTICALS LTD. trading activity
Volume7,031
Average traded price₹28.55
Last traded time03:57:35 02 Nov
Last traded quantity152
Circuit
L
H
₹22.18
₹33.26
52-week
L
H
₹25.60
₹53.90
Mkt Cap Cr
97.76
P/E
-22.18
P/B
2.05
ROA
-5.07%
ROE
-29.76%
ROCE
-20.97%
Quick Ratio
0.44
EV/EBITDA
-61.74

Based on fundamentals, this stock's

Performance: 1 out of 5, Very Poor
Performance
Very Poor
Pharmaids Pharma has not beaten FD return of 7%
Valuation: 1 out of 5, Overvalued
Valuation
Overvalued
Pharmaids Pharma appears overvalued compared to its peers
Earnings: 5 out of 5, Excellent
Earnings
Excellent
Pharmaids Pharma revenue, operating profit and net profit are growing
Peer Comparison
Peer comparison — key ratios
NameMkt Cap CrP/EP/BROAROEROCEQuick RatioEV/EBITDA
Sun Pharmaceutical Industries4,26,661.7438.834.789.61%13.79%18.65%2.3122.27
Divis Laboratories2,57,902.7388.1715.3914.6%15.32%19.56%3.558.97
Torrent Pharmaceuticals1,76,306.2184.09.64.7%11.42%11.37%0.7533.6
Laurus Labs1,29,242.6897.021.3311.58%22.11%20.91%0.6854.77
Zydus Lifesciences1,24,089.4827.024.588.57%18.59%17.35%0.9116.42
Dr. Reddy's Laboratories1,12,698.5340.842.94.79%7.21%8.58%1.3519.05
Cipla1,11,486.1439.063.156.6%8.18%10.8%2.521.03
Mankind Pharma1,02,796.6045.425.857.82%12.76%14.68%0.7425.01
Aurobindo Pharma96,536.9026.022.556.34%9.25%11.76%1.1512.38
Lupin91,870.1616.554.0914.47%23.76%24.88%1.429.83

Auto-generated based on historical fundamentals; not a recommendation to buy/sell.

PHARMAIDS PHARMACEUTICALS LTD. Company Background

ISIN
INE117D01018
Sector Market Cap
₹ 97.76 Cr

Pharmaids Pharmaceuticals Limited is an India-based suppliers of a range of specialty chemicals, skin care, hospital care and generic products in the areas of orthopedic, neuro and gastro, and other. The Company is engaged in the business of trading and manufacturing of generics, bulk drugs, and intermediaries, and other. The Company operates through Bulk Drugs and Intermediates segment. Its specialty chemicals products include Retinol, DL Alpha Tocopherol, D Pantothenate, Cyanocobalamin, Pyridoxine Hcl, Thiamine, Nicotinic Acid, Water Sol. Vitamin E, Coenzyme Q10 and D-Biotin. Its skin care products include Best care hands, Hands Sanitizer, Moisturizing Cream, Skinsure Plus, SkinSure Ultra, Alcohol Gel and Barrier Cream. Its hospital care products include Xepi Rub M, Facein Spray, Sod Hypochlorite, Sanmedin, Strumen G, Strumen TRIACID, Facein Eco, Facein Power 256, Facein Spray, Sod Hypochlorite, Wipes and PPE. Its generic products include Linzomust, Benfoshine, Duojoint, and other.

PHARMAIDS PHARMACEUTICALS LTD. Financial Highlights

  • Revenue: PHARMAIDS PHARMACEUTICALS LTD. reported revenue of ₹28.17 crore in FY26 vs ₹19.55 crore in FY25. It showed an increase of 44.09% on a yearly basis.
  • Operating Profit: PHARMAIDS PHARMACEUTICALS LTD. reported an operating loss of ₹16.30 crore in FY26 vs ₹17.28 crore in FY25. It showed an increase of 5.67% on a year-on-year basis.
  • Net Profit: PHARMAIDS PHARMACEUTICALS LTD. reported a net loss of ₹11.57 crore in FY26 vs ₹13.51 crore in FY25. It showed an increase of 14.36% on a yearly basis.

PHARMAIDS PHARMACEUTICALS LTD. Quarterly Result Highlights

  • PHARMAIDS PHARMACEUTICALS LTD. reported revenue of ₹4.17 crore in Jun 2026, compared with ₹7.28 crore in Mar 2026, representing a decrease of 42.72% on a quarter-on-quarter (QoQ) basis.
  • PHARMAIDS PHARMACEUTICALS LTD. reported an operating profit of ₹2.41 crore in Jun 2026, compared with ₹1.46 crore in Mar 2026, representing an increase of 265.07% on a quarter-on-quarter (QoQ) basis.
  • PHARMAIDS PHARMACEUTICALS LTD. reported a profit of ₹1.87 crore in Jun 2026, compared with ₹1.08 crore in Mar 2026, reflecting an increase of 273.15% on a QoQ basis.
  • The earnings per share (EPS) of PHARMAIDS PHARMACEUTICALS LTD. stood at ₹3.31 during Jun 2026.

Data Source: BSE, Company announcements

Securities shown are illustrative, not recommendations. Past performance does not guarantee future results.

Promoters
32.99%
FII
0.00%
Other DII
0.00%
Retail and other
67.01%
Mutual funds
0.00%
Foreign Institutional Investor (FII)
FII shareholding by period
Dec 20250.00%
Mar 20260.00%
Jun 20260.00%
Sep 20260.00%

PHARMAIDS PHARMACEUTICALS LTD. Investment Returns

1 day
-2.46%
1 week
-4.15%
1 month
-5.71%
1 year
-44.68%
3 years
-41.02%
5 years
+77.69%

PHARMAIDS PHARMACEUTICALS LTD. Share Price History

PHARMAIDS PHARMACEUTICALS LTD. share price history by day, showing open and close prices and the percentage change
Day
Open / Close
Change %
30 Oct 26
₹28.00 / ₹27.72
-2.46%
29 Oct 26
₹30.30 / ₹28.42
+3.27%
28 Oct 26
₹29.90 / ₹27.52
-4.38%
27 Oct 26
₹28.60 / ₹28.78
+0.95%
Show more

PHARMAIDS PHARMACEUTICALS LTD. Financials

Full statement

Income Statement · Consolidated

Income Statement · Consolidated — all values in INR Crore
ParticularsMar 2026Mar 2025Mar 2024Mar 2023
Revenue₹27.88₹19.45₹15.11₹0.00
Other Income₹0.29₹0.10₹0.88₹0.00
Total Revenue₹28.17₹19.55₹15.99₹0.00
Total Expenses₹46.94₹36.73₹30.79₹9.91
Profit Before Tax-₹16.30-₹17.28-₹15.62-₹9.91
Tax-₹4.73-₹3.77-₹3.78-₹2.35
Profit After Tax-₹11.57-₹13.51-₹11.84-₹7.56
EPS - Basic-₹3.31-₹3.05-₹3.56-₹5.86
EPS - Diluted-₹3.31-₹3.05-₹3.56-₹5.86

Cash Flow · Consolidated

Cash Flow · Consolidated — all values in INR Crore
ParticularsMar 2026Mar 2025Mar 2024Mar 2023
Profit before tax-₹16.30-₹17.28-₹15.62-₹9.91
Income before WC changes-₹14.03-₹12.47-₹11.74-₹9.86
Change in Assets₹10.37-₹17.54₹0.55₹6.15
Change in Liabilities-₹0.39₹14.96₹0.57-₹0.31
Change in WC₹9.97-₹2.58₹1.12₹5.84
Cash flow from Operations-₹4.06-₹15.11-₹10.62-₹4.02
Cash flow from Investing₹23.34-₹12.22-₹74.99-₹4.94
Cash flow from Financing-₹19.97₹23.36₹77.66₹21.31
Total Cash Flow-₹0.69-₹3.98-₹7.95₹12.35
Cash (Start of the year)₹0.82₹4.80₹12.75₹0.41
Cash (End of the year)₹0.13₹0.82₹4.80₹12.75

Balance Sheet · Consolidated

Balance Sheet · Consolidated — all values in INR Crore
ParticularsMar 2026Mar 2025Mar 2024Mar 2023
Non-Current Assets₹76.27₹98.87₹77.81₹7.07
Current Assets₹10.99₹20.99₹13.53₹17.51
Total Assets₹87.26₹119.85₹91.34₹24.59
Current Liabilities₹24.01₹28.71₹11.58₹2.13
Net Current Asset-₹13.02-₹7.73₹1.96₹15.39
Non-Current Liabilities₹15.65₹36.10₹9.27₹0.00
Equity Capital₹47.60₹55.04₹70.50₹22.46
Total Equity & Liabilities₹87.26₹119.85₹91.34₹24.59

Income Statement · Standalone

Income Statement · Standalone — all values in INR Crore
ParticularsMar 2026Mar 2025Mar 2024Mar 2023
Revenue₹10.60₹2.34₹0.03₹0.00
Other Income₹0.66₹1.02₹0.80₹0.00
Total Revenue₹11.26₹3.36₹0.82₹0.00
Total Expenses₹28.33₹11.95₹6.91₹9.91
Profit Before Tax-₹13.95-₹8.59-₹6.09-₹9.91
Tax-₹3.52-₹1.31-₹1.14-₹2.35
Profit After Tax-₹10.44-₹7.28-₹4.95-₹7.56
EPS - Basic-₹2.95-₹2.06-₹2.18-₹5.86
EPS - Diluted-₹2.95-₹2.06-₹2.18-₹5.86

Cash Flow · Standalone

Cash Flow · Standalone — all values in INR Crore
ParticularsMar 2026Mar 2025Mar 2024Mar 2023
Profit before tax-₹13.95-₹8.59-₹6.09-₹9.91
Income before WC changes-₹14.01-₹6.62-₹3.44-₹9.86
Change in Assets₹9.59-₹15.16₹1.33₹6.16
Change in Liabilities₹0.88₹14.05-₹1.33-₹0.32
Change in WC₹10.48-₹1.11₹0.00₹5.84
Cash flow from Operations-₹3.53-₹7.72-₹3.44-₹4.02
Cash flow from Investing₹24.53-₹18.90-₹72.51-₹4.94
Cash flow from Financing-₹21.36₹24.64₹65.66₹21.31
Total Cash Flow-₹0.36-₹1.99-₹10.29₹12.35
Cash (Start of the year)₹0.47₹2.46₹12.75₹0.41
Cash (End of the year)₹0.11₹0.47₹2.46₹12.75

Balance Sheet · Standalone

Balance Sheet · Standalone — all values in INR Crore
ParticularsMar 2026Mar 2025Mar 2024Mar 2023
Non-Current Assets₹78.14₹102.04₹80.24₹6.27
Current Assets₹5.82₹12.68₹4.76₹18.28
Total Assets₹83.96₹114.72₹85.00₹24.55
Current Liabilities₹15.64₹15.23₹1.10₹2.12
Net Current Asset-₹9.82-₹2.55₹3.66₹16.16
Non-Current Liabilities₹14.94₹35.70₹12.84₹0.00
Equity Capital₹53.38₹63.79₹71.06₹22.43
Total Equity & Liabilities₹83.96₹114.72₹85.00₹24.55
* All values are in INR Crore
PHARMAIDS PHARMACEUTICALS LTD. market depth
Bid quantityBid priceAsk priceAsk quantity
35128.1400
0000
0000
0000
0000
Total bid quantity351
Total ask quantity0
PHARMAIDS PHARMACEUTICALS LTD. technical summary
Bearish indicators2
Neutral indicators3
Bullish indicators3
OverallSlightly Bullish
by SEBI experts

Expert Pick

EXPPICK
Stop-loss
Stop-loss is locked. Sign in to view.
Entry price
Entry price is locked. Sign in to view.
Target
Target is locked. Sign in to view.
Indicator
Value
Verdict
RSI (14)
38.8
Neutral
ATR (14)
2.35
Neutral
STOCH(9,6)
14.4
Bullish
STOCH RSI (14)
15.41
Bullish
ADX(9)
28.87
Bearish
UO(9)
31.71
Neutral
ROC(12)
-7.54
Bearish
WillR(14)
-86.91
Bullish
Period
Simple value
Exponential vaue
5D
28.19
28.21
10D
28.88
28.69
20D
29.61
29.26
50D
30.28
30.17
100D
31.59
30.89
Volume trend — traded volume by day
2 Nov0L
30 Oct0L
29 Oct0L
28 Oct0L
27 Oct0L
26 Oct0L
Average0L

Technical indicators used here are for indicative purposes only. Kindly do not treat it as an investment or trading advice

Compare against other stocks

PHARMAIDS PHARMACEUTICALS LTD.
Pharmaceuticals
Add Stock
Add Another

PHARMAIDS PHARMACEUTICALS LTD. Returns Calculator

Top Gainers

ITI Share Price
₹259.14
+43.19 (+20%)
ENGINERSIN Share Price
₹289.65
+37.8 (+15.01%)
AFFLE Share Price
₹1506.50
+164.7 (+12.27%)
PRAJIND Share Price
₹271.13
+29.43 (+12.18%)
DIXON Share Price
₹12319.00
+1319 (+11.99%)
See more

Top Losers

INDIGOPNTS Share Price
₹870.00
-127.3 (-12.76%)
CLEAN Share Price
₹662.60
-53 (-7.41%)
ZEEL Share Price
₹61.58
-4.82 (-7.26%)
SYRMA Share Price
₹1512.00
-113.3 (-6.97%)
POLICYBZR Share Price
₹931.00
-69.1 (-6.91%)
See more

PHARMAIDS PHARMACEUTICALS LTD. Share Price FAQs

Please be aware that PHARMAIDS PHARMACEUTICALS LTD. stock prices are subject to continuous fluctuations due to various factors.